Large-scale testing (Phase 3)UnknownNCT03391739What this trial is testingCART-19 Cells For R/R B-ALLWho this might be right forRelapsed/Refractory B-cell ALL Fujian Medical University 20
Not applicableLooking for participantsNCT06450067What this trial is testingInaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic LeukemiaWho this might be right forB-cell Acute Lymphoblastic Leukemia Juventas Cell Therapy Ltd. 200
Not applicableLooking for participantsNCT06355739What this trial is testingCD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+Who this might be right forB Lymphocytic LeukemiaB Lymphoblastic Lymphoma Zhu Xiaofan 60
Testing effectiveness (Phase 2)Study completedNCT04238819What this trial is testingAbemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaWho this might be right forRelapsed Solid TumorRefractory Solid Tumor Eli Lilly and Company 47
Large-scale testing (Phase 3)Active Not RecruitingNCT06956170What this trial is testingAll Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma GlaxoSmithKline 21
Testing effectiveness (Phase 2)Looking for participantsNCT07283822What this trial is testingAmping up With PemJAKWho this might be right forNon-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more Seda S. Tolu 53
Testing effectiveness (Phase 2)Study completedNCT00875056What this trial is testingStudy of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)Who this might be right forLymphoma Merck Sharp & Dohme LLC 56
Early research (Phase 1)Ended earlyNCT03601819What this trial is testingPacritinib in Relapsed/Refractory Lymphoproliferative DisordersWho this might be right forLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralChronic Lymphocytic Leukemia+4 more University of Michigan Rogel Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT04544592What this trial is testingUCD19 CarT in Treatment of Pediatric B-ALL and B-NHLWho this might be right forB-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma University of Colorado, Denver 45
Early research (Phase 1)Study completedNCT02240719What this trial is testingEverolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic CancerWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more University of California, Davis 20
Large-scale testing (Phase 3)Ended earlyNCT02366663What this trial is testingBEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCLWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma City of Hope Medical Center 3
Not applicableStudy completedNCT01233921What this trial is testingPalifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more Martin, Paul 6
Testing effectiveness (Phase 2)Looking for participantsNCT07255963What this trial is testingPirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCLWho this might be right forDLBCL - Diffuse Large B Cell Lymphoma The First Affiliated Hospital of Soochow University 29
Testing effectiveness (Phase 2)WithdrawnNCT04882163What this trial is testingStudy to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell LymphomaWho this might be right forLymphoma, B-Cell Celgene
Testing effectiveness (Phase 2)UnknownNCT04723914What this trial is testingDual Target CAR-T Cells in B-cell LymphomaWho this might be right forLymphoma, B-CellRelapse/RecurrenceRefractory Lymphoma+1 more YuLi 20
Early research (Phase 1)Study completedNCT01671904What this trial is testingVenetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Genentech, Inc. 84
Testing effectiveness (Phase 2)UnknownNCT06503094What this trial is testingCD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsWho this might be right forB-Cell Lymphoblastic Leukemia/Lymphoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Early research (Phase 1)UnknownNCT05487651What this trial is testingAllogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell MalignanciesWho this might be right forNHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more Athenex, Inc. 36
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58